It was in a thread between two people with B-OM named twice before. The only variable in the two B-OM arms was the Cisplatin dosage interval and it appeared to have a very large affect on the B-OM efficacy.. What else could he have been talking about? Obviously two people discussing a trial they are familiar with know this.
If you were having that conversation face to face with him, would he have confused you with that statement?
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links